Skip to main content

Table 2 Baseline characteristics of study subjects

From: Validation of rheumatoid arthritis diagnoses in health care utilization data

Algorithms

A. At least 2 claims for RA

B. At least 3 claims for RA

C. At least 2 claims from a rheumatologista

No claims for RA

Number

131

110

84

39

Age in years, mean (SD)

79.1 (6.7)

78.8 (6.6)

78.7 (7.0)

80.1 (8.4)

Females, number (percentage)

115 (87.8)

96 (87.3)

73 (86.9)

26 (66.7)

Caucasians, number (percentage)

129 (98.5)

109 (99)

83 (98.8)

38 (97.4)

Comorbidity index, mean (SD)

2.6 (2.3)

2.6 (2.3)

2.7 (2.4)

1.8 (2.5)

Comorbidity index >0, number (percentage)

109 (83.2)

92 (83.6)

72 (85.7)

20 (51.3)

Rheumatology visits, mean (SD)

1.9 (3.6)

2.2 (3.8)

3.0 (4.1)

0 (0)

DMARD use, number (percentage)

58 (44.3)

56 (50.9)

45 (53.6)

1 (2.6)

  1. aAt least 7 days were required between the claims. DMARD, disease-modifying antirheumatic drug; RA, rheumatoid arthritis; SD, standard deviation.